| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0065-230X(04)91002-0 |
| P698 | PubMed publication ID | 15327888 |
| P2093 | author name string | Beatrice S Knudsen | |
| Magnus Edlund | |||
| P2860 | cites work | A novel germ line juxtamembrane Met mutation in human gastric cancer | Q40847293 |
| Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines | Q40878257 | ||
| Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway . | Q40905632 | ||
| Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction | Q40923564 | ||
| The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. | Q40934001 | ||
| The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. | Q40939412 | ||
| c-met proto-oncogene expression in benign and malignant human prostate tissues | Q40981774 | ||
| Tyrosine Phosphorylation of Focal Adhesion Kinase Stimulated by Hepatocyte Growth Factor Leads to Mitogen-activated Protein Kinase Activation | Q41007034 | ||
| Regulation of lnvasive Potential of Human Prostate Cancer Cell Lines by Hepatocyte Growth Factor | Q41034938 | ||
| Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo | Q41052630 | ||
| Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. | Q41159496 | ||
| Interleukin-6: a candidate mediator of human prostate cancer morbidity | Q41362792 | ||
| Human leucocyte heparan sulphate proteoglycans and their roles in inflammation | Q41370201 | ||
| Identification of a cell-type-specific transcriptional repressor in the promoter region of the mouse hepatocyte growth factor gene | Q41431686 | ||
| Characterization of ALVA-41 cells, a new human prostatic cancer cell line | Q41440606 | ||
| The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells | Q41563732 | ||
| Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines. | Q41587684 | ||
| Human primary prostate tumor cell line, ALVA‐31: A new model for studying the hormonal regulation of prostate tumor cell growth | Q41587993 | ||
| A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. | Q41615181 | ||
| HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cells | Q41696277 | ||
| The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk. | Q41758116 | ||
| Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis | Q41899984 | ||
| Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy | Q41977380 | ||
| Inhibition of epithelial ductal branching in the prostate by sonic hedgehog is indirectly mediated by stromal cells | Q42438028 | ||
| Intermediate basal cells of the prostate: in vitro and in vivo characterization | Q42439698 | ||
| Keratin profiles in normal/hyperplastic prostates and prostate carcinoma | Q42454819 | ||
| Syndecan-1 expression in locally invasive and metastatic prostate cancer | Q42457370 | ||
| Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium | Q42463087 | ||
| Comparison of marker protein expression in benign prostatic hyperplasia in vivo and in vitro | Q42484157 | ||
| Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy | Q42492179 | ||
| Branching activity in the human prostate: a closer look at the structure of small glandular buds | Q42500472 | ||
| Cell differentiation lineage in the prostate | Q42515180 | ||
| Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy | Q42524360 | ||
| Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells | Q42528668 | ||
| Growth Factor–dependent Activation of αvβ3 Integrin in Normal Epithelial Cells: Implications for Tumor Invasion | Q42796734 | ||
| p63 is a prostate basal cell marker and is required for prostate development | Q24290591 | ||
| Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation | Q24306433 | ||
| Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 | ||
| A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer | Q24338270 | ||
| Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors | Q24339620 | ||
| AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. | Q24540534 | ||
| Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models | Q24629814 | ||
| Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor | Q24631156 | ||
| Syndecan-1 expression has prognostic significance in head and neck carcinoma | Q24650029 | ||
| Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. | Q24746259 | ||
| Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis | Q24801546 | ||
| Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding | Q27766474 | ||
| Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk | Q28137768 | ||
| Met receptor tyrosine kinase: enhanced signaling through adapter proteins | Q28140219 | ||
| Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts | Q38314606 | ||
| Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors | Q38344823 | ||
| Decreased expression of catenins (? and ?), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas | Q38458462 | ||
| CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture. | Q38472704 | ||
| The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus | Q39646594 | ||
| Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells | Q40021756 | ||
| Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction | Q40560399 | ||
| Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium | Q40598257 | ||
| The chemokine KC regulates HGF-stimulated epithelial cell morphogenesis | Q40619606 | ||
| Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells | Q40646743 | ||
| Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells | Q40736171 | ||
| Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion | Q40738685 | ||
| A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth | Q40765252 | ||
| Sustained activation of extracellular signal-regulated kinase stimulated by hepatocyte growth factor leads to integrin alpha 2 expression that is involved in cell scattering | Q40814942 | ||
| Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells | Q28140678 | ||
| Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease | Q28144714 | ||
| HGF/SF-met signaling in the control of branching morphogenesis and invasion | Q28202466 | ||
| Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein | Q28210330 | ||
| Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition | Q28212407 | ||
| Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways | Q28212733 | ||
| Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells | Q28217019 | ||
| Met, metastasis, motility and more | Q28235183 | ||
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family | Q28285975 | ||
| Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase | Q28286701 | ||
| Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis | Q28295920 | ||
| Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor | Q28345285 | ||
| Scatter factor/hepatocyte growth factor is essential for liver development | Q28504542 | ||
| Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium | Q28509263 | ||
| Targeted disruption of the Nkx3.1 gene in mice results in morphogenetic defects of minor salivary glands: parallels to glandular duct morphogenesis in prostate | Q28513101 | ||
| Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate | Q28574557 | ||
| Sonic hedgehog regulates prostatic growth and epithelial differentiation | Q28580501 | ||
| Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis | Q28587743 | ||
| Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development | Q28592773 | ||
| Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites | Q30309352 | ||
| Androgen-repressed phenotype in human prostate cancer | Q30454285 | ||
| Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator | Q30816464 | ||
| The met proto-oncogene receptor and lumen formation | Q30991648 | ||
| The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase | Q33605698 | ||
| Transforming growth factor-beta in benign and malignant prostate | Q33645241 | ||
| Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma | Q33667939 | ||
| Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis | Q33923757 | ||
| The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions | Q33961658 | ||
| Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44. | Q33963349 | ||
| Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas | Q34053843 | ||
| Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth | Q34158970 | ||
| High expression of the Met receptor in prostate cancer metastasis to bone | Q34163761 | ||
| Morphogenesis of prostate cancer | Q34243355 | ||
| Isolation of a human prostate carcinoma cell line (DU 145) | Q34255312 | ||
| Mechanism of met oncogene activation | Q42811433 | ||
| Novel mutations of the MET proto-oncogene in papillary renal carcinomas. | Q42815807 | ||
| Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells | Q42830729 | ||
| A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein | Q42832806 | ||
| TGF-beta1 perturbs vascular development and inhibits epithelial differentiation in fetal lung in vivo | Q43679029 | ||
| Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features | Q44057337 | ||
| Smooth muscle releases an epithelial cell scatter factor which binds to heparin | Q44224038 | ||
| The structural biology of growth factor receptor activation | Q44368469 | ||
| Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin. | Q44440479 | ||
| Possible mechanism of dexamethasone therapy for prostate cancer: Suppression of circulating level of interleukin‐6 | Q44441026 | ||
| The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo. | Q44503111 | ||
| Orchiectomy Increases Bone Marrow Interleukin-6 Levels in Mice | Q45110162 | ||
| Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas | Q45345804 | ||
| Molecular cloning of a new transforming gene from a chemically transformed human cell line. | Q45345810 | ||
| CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy | Q45876484 | ||
| Regulation of migration of primary prostate epithelial cells by secreted factors from prostate stromal cells | Q47694776 | ||
| Epidermal growth factor (EGF)- and scatter factor/hepatocyte growth factor (SF/HGF)-mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9 | Q47903225 | ||
| Role of morphogenetic factors in metastasis of mammary carcinoma cells | Q52996861 | ||
| The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice | Q53426264 | ||
| E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology | Q53999986 | ||
| Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer | Q57782605 | ||
| Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma | Q58324023 | ||
| Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met | Q58324027 | ||
| Cortisol Decreases Hepatocyte Growth Factor Levels in Human Osteoblast-Like Cells | Q61480386 | ||
| Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met) | Q62496773 | ||
| Morphogenesis of prostatic carcinoma | Q70061158 | ||
| Testosterone, dihydrotestosterone and androstanediols in plasma, testes and prostates of rats during development | Q71460002 | ||
| Altered expression of CD44 in human prostate cancer during progression | Q71802064 | ||
| HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-beta | Q72638374 | ||
| Interleukin-6 induces proliferation of rat hepatocytes in vivo | Q73011056 | ||
| The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease | Q73106884 | ||
| Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer | Q73135517 | ||
| Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy | Q73236066 | ||
| Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin | Q73394978 | ||
| Expression of syndecan-1 is common in human lung cancers independent of expression of epidermal growth factor receptor | Q73411359 | ||
| Heparan sulfate proteoglycan expression in human lung-cancer cells | Q73507963 | ||
| Involvement of focal adhesion kinase in hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells | Q73538283 | ||
| Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas | Q73586595 | ||
| Prostatic ductal system in rats: Tissue-specific expression and regional variation in stromal distribution of transforming growth factor-β1 | Q73690899 | ||
| Radioimmunoscintigraphy of tumors autocrine for human met and hepatocyte growth factor/scatter factor | Q73814020 | ||
| Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential | Q73841954 | ||
| Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation | Q73843666 | ||
| High syndecan-1 expression is associated with favourable outcome in squamous cell lung carcinoma treated with radical surgery | Q73965564 | ||
| HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity | Q74121592 | ||
| E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens | Q77304979 | ||
| Hepatocyte growth factor induces tubulogenesis of primary renal proximal tubular epithelial cells | Q77853079 | ||
| Androgens modulate interleukin-6 production by gingival fibroblasts in vitro | Q77974127 | ||
| Progression-linked overexpression of c-Met in prostatic intraepithelial neoplasia and latent as well as clinical prostate cancers | Q78148740 | ||
| Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer | Q78225972 | ||
| Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells | Q34340236 | ||
| Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice | Q34420980 | ||
| Efficient Cellular Transformation by the Met Oncoprotein Requires a Functional Grb2 Binding Site and Correlates with Phosphorylation of the Grb2-associated Proteins, Cbl and Gab1 | Q34434226 | ||
| Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356 | Q34434985 | ||
| Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation | Q34712138 | ||
| Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion | Q34764852 | ||
| Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites | Q34929028 | ||
| Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use. | Q35054675 | ||
| The "Gab" in signal transduction. | Q35082143 | ||
| Hormonal, cellular, and molecular control of prostatic development | Q35088639 | ||
| Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor | Q35144580 | ||
| How to make tubes: signaling by the Met receptor tyrosine kinase | Q35147372 | ||
| Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice | Q35229384 | ||
| Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation | Q35277738 | ||
| Hsp90 as a therapeutic target in prostate cancer | Q35565240 | ||
| Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions | Q35786210 | ||
| Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells | Q35829375 | ||
| Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer | Q35829554 | ||
| Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck | Q36080017 | ||
| Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells | Q36223889 | ||
| Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros | Q36235129 | ||
| Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells | Q36236279 | ||
| Motogenic and morphogenic activity of epithelial receptor tyrosine kinases | Q36236949 | ||
| EphA kinase activation regulates HGF-induced epithelial branching morphogenesis | Q36325486 | ||
| Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice | Q36326357 | ||
| Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network | Q36557528 | ||
| A Novel Transcriptional Regulatory Region within the Core Promoter of the Hepatocyte Growth Factor Gene Is Responsible for Its Inducibility by Cytokines via the C/EBP Family of Transcription Factors | Q36572989 | ||
| Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor | Q36705281 | ||
| The mutationally activated Met receptor mediates motility and metastasis | Q36735738 | ||
| Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching | Q36851915 | ||
| Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90 | Q37044062 | ||
| Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor | Q37404891 | ||
| Etiology and disease process of benign prostatic hyperplasia | Q38211704 | ||
| Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity | Q38293448 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 31-67 | |
| P577 | publication date | 2004-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Advances in Cancer Research | Q3113522 |
| P1476 | title | Prostate cancer and the met hepatocyte growth factor receptor | |
| P478 | volume | 91 |
| Q34185858 | A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings |
| Q38131735 | Abiraterone acetate: targeting persistent androgen dependence in castration-resistant prostate cancer |
| Q26799813 | Androgen deprivation of prostate cancer: Leading to a therapeutic dead end |
| Q26866135 | Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinases |
| Q38964120 | C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition. |
| Q35036800 | Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling |
| Q39085630 | Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions |
| Q33664004 | Cancer associated fibroblasts in cancer pathogenesis |
| Q54571801 | Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. |
| Q33718726 | Efficacy of c-Met inhibitor for advanced prostate cancer |
| Q90397845 | Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells |
| Q53220940 | Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis |
| Q26827975 | Growth factor and signaling pathways and their relevance to prostate cancer therapeutics |
| Q36077939 | Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells. |
| Q42414387 | High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer |
| Q36239069 | Hormone-refractory prostate cancer in the Lobund-Wistar rat. |
| Q38177689 | Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases |
| Q34184870 | KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer |
| Q81617082 | MET orchestrates cancer and blood coagulation |
| Q26864988 | Met in urological cancers |
| Q30446159 | Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells |
| Q54949068 | Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistance. |
| Q38091296 | Novel chemotherapies in development for management of castration-resistant prostate cancer |
| Q34249263 | Novel therapies for metastatic castrate-resistant prostate cancer |
| Q24299743 | Pro-urokinase-type plasminogen activator is a substrate for hepsin |
| Q39210179 | Prostate cancer stem‐like cells/cancer‐initiating cells have an autocrine system of hepatocyte growth factor |
| Q90643576 | Protein tyrosine kinase 6 signaling in prostate cancer |
| Q37648868 | RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization |
| Q38205441 | RasGRP Ras guanine nucleotide exchange factors in cancer |
| Q34203989 | RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype |
| Q35084939 | Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate |
| Q90114206 | Resveratrol Suppresses Prostate Cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by Prostate Stromal Cells and Upregulation of E-cadherin by Prostate Cancer Epithelial Cells |
| Q42530532 | Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer. |
| Q39369722 | Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer. |
| Q37968256 | Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer |
| Q37705831 | Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures |
| Q37355741 | Stroma-epithelium crosstalk in prostate cancer |
| Q33383797 | TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. |
| Q46585967 | Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone |
| Q40343230 | Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases |
| Q48635543 | The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival |
| Q37621003 | The function, proteolytic processing, and histopathology of Met in cancer |
| Q42059641 | Trading in your spindles for blebs: the amoeboid tumor cell phenotype in prostate cancer |
| Q46791384 | Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease |
| Q38259197 | Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level |
| Q36580342 | β4 Integrin signaling induces expansion of prostate tumor progenitors |
Search more.